Insider Trading23 Jun 2026, 12:10 pm
Shukra Pharma Closes Trading Window for Q1 FY27 Results
AI Summary
Shukra Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended June 30, 2026. The decision aligns with SEBI regulations and the company's Insider Trading Code, prohibiting transactions by promoters, directors, KMPs, insiders, and connected persons, including their immediate relatives. The specific date for the Board Meeting to approve these financial results will be announced later.
Key Highlights
- Trading window closed for Q1 FY27 results announcement.
- Prohibits trading by insiders, promoters, directors, and relatives.
- Closure effective from July 1, 2026, until 48 hours post-results.
- Aims to comply with SEBI's Prohibition of Insider Trading Regulations.
- Board meeting date for results declaration to be announced soon.
Price Impact
More from SHUKRAPHAR